[Clinical and laboratory support for multiple-modality treatment of rheumatic patients with mitral valve disease].
In 158 rheumatic patients with mitral valvular disease (MVD), clinical-and-laboratory indices were studied together with a possibility for correction of the detected disorders in a multiple-modality staged treatment involving basic drug therapy, EHF-therapy, and sanatorium-health resort stage of rehabilitation. It has been found out that EHF-therapy and sanatorium-health resort treatment have a positive effect on the clinical course of the trouble and on the laboratory indices for the inflammatory process contributing to optimization of medicamentous treatment of rheumatic patients with MVD.
Iakymenko
O O
OO
Mararenko
A A
AA
D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000150:complications*; D001798:Blood Proteins / Q000032:analysis; D002097:C-Reactive Protein / Q000032:analysis; D003131:Combined Modality Therapy; D004452:Echocardiography; D004562:Electrocardiography; D004574:Electromagnetic Fields; D005080:Exercise Test; D005260:Female; D006294:Health Resorts; D006349:Heart Valve Diseases / Q000209:etiology / Q000534:rehabilitation / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency; D026741:Physical Therapy Modalities / Q000379:methods; D012214:Rheumatic Heart Disease / Q000150:complications / Q000534:rehabilitation / Q000628:therapy*; D013291:Streptococcus / Q000276:immunology; D016896:Treatment Outcome; D014455:Ukraine
D000907:Antibodies, Bacterial; D001798:Blood Proteins; D002097:C-Reactive Protein